Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. According to Bloomberg, the latest round was designed to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Somerville company's success ...
I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...
Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...
LOUISVILLE, KY, UNITED STATES, February 18, 2026 /EINPresswire.com/ — Justice AV Solutions (JAVS), the nation’s leading provider of digital recording and ...
Google has announced that using its newly incorporated Lyria 3 model, Gemini users will be able to generate 30-second music tracks based on a prompt, or remix an existing track to their liking. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results